219 related articles for article (PubMed ID: 22104308)
41. Recombinant soluble thrombomodulin for postoperative disseminated intravascular coagulation.
Hashimoto D; Chikamoto A; Miyanari N; Ohara C; Kuramoto M; Horino K; Ohshima H; Baba H
J Surg Res; 2015 Aug; 197(2):405-11. PubMed ID: 25972310
[TBL] [Abstract][Full Text] [Related]
42. [Successful treatment with recombinant thrombomodulin for disseminated intravascular coagulation complicated with hemophagocytic syndrome].
Yamazaki H; Kondo T; Tatsumi G; Kotani S; Arai Y; Shirakawa K; Kitano T; Hishizawa M; Kadowaki N; Takaori-Kondo A
Rinsho Ketsueki; 2015 Mar; 56(3):312-6. PubMed ID: 25876785
[TBL] [Abstract][Full Text] [Related]
43. Clinical Outcomes of Recombinant Human-soluble Thrombomodulin Treatment for Disseminated Intravascular Coagulation in Solid Tumors.
Kashiwagi S; Asano Y; Takahashi K; Shibutani M; Amano R; Tomita S; Hirakawa K; Ohira M
Anticancer Res; 2019 May; 39(5):2259-2264. PubMed ID: 31092417
[TBL] [Abstract][Full Text] [Related]
44. The efficacy and safety of antithrombin and recombinant human thrombomodulin combination therapy in patients with severe sepsis and disseminated intravascular coagulation.
Yasuda N; Goto K; Ohchi Y; Abe T; Koga H; Kitano T
J Crit Care; 2016 Dec; 36():29-34. PubMed ID: 27546744
[TBL] [Abstract][Full Text] [Related]
45. The efficacy of recombinant human soluble thrombomodulin for obstetric disseminated intravascular coagulation: a retrospective study.
Yoshihara M; Uno K; Tano S; Mayama M; Ukai M; Kondo S; Kokabu T; Kishigami Y; Oguchi H
Crit Care; 2015 Oct; 19():369. PubMed ID: 26481315
[TBL] [Abstract][Full Text] [Related]
46. Recombinant human thrombomodulin in the treatment of acute myeloid leukemia patients complicated by disseminated intravascular coagulation: retrospective analysis of outcomes between patients treated with heparin and recombinant human thrombomodulin therapy.
Takezako N; Sekiguchi N; Nagata A; Homma C; Takezako Y; Noto S; Natori K; Miwa A
Thromb Res; 2015 Jul; 136(1):20-3. PubMed ID: 25934464
[TBL] [Abstract][Full Text] [Related]
47. Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies.
Papageorgiou C; Jourdi G; Adjambri E; Walborn A; Patel P; Fareed J; Elalamy I; Hoppensteadt D; Gerotziafas GT
Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):8S-28S. PubMed ID: 30296833
[TBL] [Abstract][Full Text] [Related]
48. Successful treatment of sepsis-induced disseminated intravascular coagulation in a patient with idiopathic thrombocytopenic purpura using recombinant human soluble thrombomodulin.
Koga T; Inoue D; Okada A; Aramaki T; Yamasaki S; Nakashima M; Kawakami A; Eguchi K
Rheumatol Int; 2011 Dec; 31(12):1657-9. PubMed ID: 21240494
[TBL] [Abstract][Full Text] [Related]
49. Recombinant soluble human thrombomodulin (thrombomodulin alfa) in the treatment of neonatal disseminated intravascular coagulation.
Shirahata A; Mimuro J; Takahashi H; Kitajima I; Tsuji H; Eguchi Y; Matsushita T; Kajiki M; Honda G; Sakata Y
Eur J Pediatr; 2014 Mar; 173(3):303-11. PubMed ID: 24005342
[TBL] [Abstract][Full Text] [Related]
50. Thrombomodulin alfa in the treatment of infectious patients complicated by disseminated intravascular coagulation: subanalysis from the phase 3 trial.
Aikawa N; Shimazaki S; Yamamoto Y; Saito H; Maruyama I; Ohno R; Hirayama A; Aoki Y; Aoki N
Shock; 2011 Apr; 35(4):349-54. PubMed ID: 21068698
[TBL] [Abstract][Full Text] [Related]
51. Efficacy and Bleeding Risk of Antithrombin Supplementation in Patients With Septic Disseminated Intravascular Coagulation: A Third Survey.
Iba T; Gando S; Saitoh D; Ikeda T; Anan H; Oda S; Kitamura N; Mori S; Kotani J; Kuroda Y
Clin Appl Thromb Hemost; 2017 Jul; 23(5):422-428. PubMed ID: 27161759
[TBL] [Abstract][Full Text] [Related]
52. Factors influencing the effectiveness of recombinant human soluble thrombomodulin on disseminated intravascular coagulation: a retrospective study.
Asai Y; Yamamoto T; Kito D; Ichikawa K; Abe Y
J Pharm Health Care Sci; 2020 Dec; 6(1):26. PubMed ID: 33292809
[TBL] [Abstract][Full Text] [Related]
53. [Case report of disseminated carcinomatosis of the bone marrow originating from gastric cancer with cancer-related disseminated intravascular coagulation successfully treated with recombinant human soluble thrombomodulin].
Kawamoto H; Uchida Y; Ueda S; Yanagita S; Terajima H
Gan To Kagaku Ryoho; 2015 Mar; 42(3):363-5. PubMed ID: 25812509
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of recombinant human soluble thrombomodulin in preventing walled-off necrosis in severe acute pancreatitis patients.
Eguchi T; Tsuji Y; Yamashita H; Fukuchi T; Kanamori A; Matsumoto K; Hasegawa T; Koizumi A; Kitada R; Tsujimae M; Iwatsubo T; Koyama S; Ubukata S; Fujita M; Okada A
Pancreatology; 2015; 15(5):485-490. PubMed ID: 26320826
[TBL] [Abstract][Full Text] [Related]
55. Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin.
Ikezoe T
Int J Hematol; 2014 Jul; 100(1):27-37. PubMed ID: 24217998
[TBL] [Abstract][Full Text] [Related]
56. The effect of recombinant human soluble thrombomodulin on disseminated intravascular coagulation in an abdominal aortic aneurysm.
Hoshina K; Shigematsu K; Hosaka A; Okamoto H; Miyata T; Watanabe T
Blood Coagul Fibrinolysis; 2014 Jun; 25(4):389-91. PubMed ID: 24378974
[TBL] [Abstract][Full Text] [Related]
57. [Successful treatment using recombinant thrombomodulin for disseminated intravascular coagulation associated with recurrent prosthetic valve endocarditis].
Masuda S; Adachi O; Ito K; Matsuo S; Hayatsu Y; Suzuki Y; Saito T; Akiyama M; Kumagai K; Motoyoshi N; Kawamoto S; Saiki Y
Kyobu Geka; 2013 Feb; 66(2):101-5. PubMed ID: 23381354
[TBL] [Abstract][Full Text] [Related]
58. Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial.
Hagiwara A; Tanaka N; Uemura T; Matsuda W; Kimura A
BMJ Open; 2016 Dec; 6(12):e012850. PubMed ID: 28039291
[TBL] [Abstract][Full Text] [Related]
59. Recombinant human soluble thrombomodulin safely and effectively rescues acute promyelocytic leukemia patients from disseminated intravascular coagulation.
Ikezoe T; Takeuchi A; Isaka M; Arakawa Y; Iwabu N; Kin T; Anabuki K; Sakai M; Taniguchi A; Togitani K; Yokoyama A
Leuk Res; 2012 Nov; 36(11):1398-402. PubMed ID: 22917769
[TBL] [Abstract][Full Text] [Related]
60. [Successful treatment with the combination of recombinant human soluble thrombomodulin and gabexate mesilate in three patients with obstetric disseminated intravascular coagulation].
Kumura T; Aoyama Y; Ichihara H; Koh S; Mugitani A; Hayakawa H; Yukioka K; Kinoshita D; Nakagawa M; Yamazaki N
Rinsho Ketsueki; 2011 Feb; 52(2):68-72. PubMed ID: 21403426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
